Treatment Options for Acute Ischemic Stroke at 10 Hours After Onset
At 10 hours after stroke onset, intravenous alteplase is NOT recommended as standard therapy, but endovascular thrombectomy remains a viable option for carefully selected patients with large vessel occlusion and salvageable brain tissue identified on advanced imaging. 1
Intravenous Thrombolysis: Not Standard at 10 Hours
- The standard time window for IV alteplase is up to 4.5 hours from symptom onset or last known well 1
- Treatment beyond 4.5 hours is not FDA-approved and falls outside established guideline recommendations for routine use 1
- The 2018 AHA/ASA guidelines establish 4.5 hours as the upper limit for standard IV alteplase administration 1
Extended Window Considerations (Beyond Guidelines)
While not standard practice at 10 hours, emerging evidence suggests potential benefit in highly selected cases:
- Perfusion imaging-selected patients may benefit from IV alteplase up to 9 hours when salvageable tissue is demonstrated on CT perfusion or MRI diffusion-weighted imaging 1, 2
- The EXTEND trial showed improved functional outcomes (35.4% vs 29.5% with placebo) when alteplase was given 4.5-9 hours after onset in patients selected by perfusion imaging, though symptomatic ICH increased (6.2% vs 0.9%) 2
- The Canadian guidelines note that MRI-selected patients (DWI-FLAIR mismatch) may benefit beyond 4.5 hours, but this requires consultation with stroke expertise and is not proven with CT-based selection 1
Critical caveat: At 10 hours, this approach is investigational and requires specialized stroke center capabilities with advanced imaging and neurological expertise 1
Endovascular Thrombectomy: Primary Option at 10 Hours
For patients with large vessel occlusion, mechanical thrombectomy is the recommended treatment at 10 hours 1, 3
Patient Selection Criteria
- Time window: Up to 24 hours from last known well for highly selected patients 1
- Imaging requirements at 10 hours: Advanced neurovascular imaging with CT perfusion or MRI diffusion-weighted imaging to demonstrate salvageable tissue 1
- Specific imaging criteria: Small ischemic core (typically ≤70 mL), substantial penumbra (≥10-15 mL), and favorable mismatch ratio 1, 3
- Target vessels: Anterior circulation large vessel occlusion (internal carotid artery, M1/proximal M2 middle cerebral artery) 1
Technical Approach
- Stent retriever devices are the standard technique, achieving recanalization rates of 72-88% 3
- Goal is modified TICI 2b/3 reperfusion 4
- Treatment provides 50% increase in good functional outcomes compared to medical therapy alone for large vessel occlusion 3
Clinical Algorithm for 10-Hour Presentation
- Immediate CT scan to exclude hemorrhage 4
- CT angiography to identify large vessel occlusion 1, 4
- If large vessel occlusion present: Obtain CT perfusion or MRI to assess salvageable tissue 1
- If favorable imaging profile: Proceed directly to mechanical thrombectomy 1
- If no large vessel occlusion or unfavorable imaging: Medical management only (antiplatelet therapy after 24 hours, supportive care) 1
Important Safety Considerations
- Do not administer IV alteplase at 10 hours outside of clinical trials or highly specialized centers with perfusion imaging capabilities 1
- Symptomatic ICH risk increases substantially with delayed thrombolysis, particularly beyond 4.5 hours 5, 2
- Hyperglycemia (>11.1 mmol/L) dramatically increases hemorrhage risk and should be corrected before any reperfusion therapy 3
- Blood pressure must be controlled to <185/110 mmHg before any intervention 1, 4
Supportive Care Measures
- Maintain oxygen saturation >94% 4
- Correct hypoglycemia immediately; treat hyperglycemia to target range 4
- Continuous cardiac monitoring for at least 24 hours 4
- Treat fever >38°C with antipyretics 4
- Avoid antiplatelet agents and anticoagulants until 24 hours after any thrombolytic therapy 4
Bottom line: At 10 hours, mechanical thrombectomy for large vessel occlusion with favorable imaging is the evidence-based treatment; IV thrombolysis is not recommended outside of research protocols with advanced perfusion imaging selection 1, 3